BIOCELL

Scope & Guideline

Fostering Excellence in Cell Research

Introduction

Explore the comprehensive scope of BIOCELL through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore BIOCELL in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0327-9545
PublisherTECH SCIENCE PRESS
Support Open AccessNo
CountryArgentina
TypeJournal
Convergefrom 1995 to 2013, from 2015 to 2024
AbbreviationBIOCELL / Biocell
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address871 CORONADO CENTER DR, SUTE 200, HENDERSON, NV 89052

Aims and Scopes

BIOCELL is a journal dedicated to the exploration of cellular and molecular biology, emphasizing the interplay between biological systems and their microenvironments. The journal aims to publish high-quality research that elucidates mechanisms underlying cellular functions, disease processes, and therapeutic interventions.
  1. Cellular and Molecular Mechanisms:
    Research articles focusing on the intricate cellular pathways and molecular mechanisms that govern various biological processes, including cell proliferation, differentiation, apoptosis, and autophagy.
  2. Stem Cell Biology and Regenerative Medicine:
    A significant focus on the properties, applications, and therapeutic potentials of stem cells, including their roles in tissue engineering, regeneration, and treatment of various diseases.
  3. Cancer Biology and Therapeutics:
    Investigations into the molecular and cellular underpinnings of cancer, including tumor microenvironment interactions, cancer stem cells, and novel therapeutic approaches.
  4. Immunology and Host-Pathogen Interactions:
    Studies that explore the immune response to pathogens, the mechanisms of immune evasion by cancer cells, and the development of immunotherapies.
  5. Bioinformatics and Systems Biology:
    Utilization of computational methods and bioinformatics tools to analyze large datasets, identify biomarkers, and understand complex biological interactions.
  6. Nanotechnology and Biomaterials:
    Research highlighting the application of nanomaterials and biomaterials in biological systems, particularly in drug delivery, diagnostics, and tissue engineering.
BIOCELL has been progressively embracing emerging trends in research, reflecting the dynamic nature of the fields of cellular and molecular biology. The following themes have gained significant traction in recent publications.
  1. Single-Cell Sequencing and Transcriptomics:
    There is a marked increase in studies utilizing single-cell sequencing technologies to explore cellular heterogeneity and gene expression profiles, particularly in cancer and immune responses.
  2. Microbiome and Host Interactions:
    Research exploring the gut microbiome's influence on health and disease, including its interactions with host cells and implications for personalized medicine, has emerged as a key area of interest.
  3. Advancements in Nanotechnology:
    The application of nanotechnology in drug delivery systems, diagnostics, and therapeutic interventions is increasingly prominent, reflecting the journal's commitment to cutting-edge research.
  4. Cancer Immunotherapy:
    A growing body of work focuses on cancer immunotherapy, including the mechanisms of immune evasion and the development of novel immunotherapeutic strategies.
  5. Epigenetic Modifications in Health and Disease:
    There is an increasing emphasis on studies investigating the role of epigenetic changes in various diseases, including cancer and metabolic disorders, highlighting their potential as therapeutic targets.
  6. Biomaterials for Tissue Engineering:
    Research on innovative biomaterials for tissue engineering applications is gaining momentum, particularly those that enhance cellular interactions and promote regeneration.

Declining or Waning

While BIOCELL has consistently focused on several core areas, certain themes appear to be waning in prominence as the journal evolves to address emerging scientific challenges and innovations.
  1. Traditional Pharmacological Studies:
    There seems to be a decline in publications centered on classical pharmacological approaches, as the journal shifts towards more innovative and integrative methodologies.
  2. In vitro Models with Limited Relevance:
    Research utilizing simplistic in vitro models that do not adequately mimic the complexity of in vivo systems appears to be decreasing, as the field moves towards more sophisticated models, including organ-on-a-chip technologies.
  3. Basic Plant Biology Studies:
    While still relevant, there is a noticeable reduction in the number of studies solely focused on fundamental plant biology, as the journal pivots towards translational research and applications in human health.
  4. Non-targeted Metabolomics:
    The focus on non-targeted metabolomics studies has diminished, likely due to the growing emphasis on targeted approaches that yield more actionable insights in therapeutic contexts.
  5. Animal Studies with Limited Clinical Relevance:
    Research involving animal models that do not translate well to human conditions is less frequently published, reflecting a trend towards studies that emphasize translational potential.

Similar Journals

Cell Communication and Signaling

Advancing the Frontiers of Cellular Interactions
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

Cell Stem Cell

Fostering Global Collaboration in Cutting-Edge Stem Cell Discoveries
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

Cellular and Molecular Bioengineering

Advancing the Frontiers of Bioengineering Research
Publisher: SPRINGERISSN: 1865-5025Frequency: 4 issues/year

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

CELL BIOLOGY INTERNATIONAL

Shaping the Future of Cell Biology and Medicine
Publisher: WILEYISSN: 1065-6995Frequency: 12 issues/year

CELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.

Cell Division

Connecting researchers through groundbreaking insights.
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Division, an esteemed journal published by BMC, serves as a critical platform for researchers in the fields of biochemistry, cell biology, and molecular biology, showcasing groundbreaking studies and novel insights in the mechanisms governing cell division. Since its establishment in 2006, this Open Access journal, based in the United Kingdom, has strived to promote rigorous scientific discourse, ensuring unrestricted access to its rich content. With a commendable impact factor reflected in its Q1 and Q2 categorizations across various biological disciplines, Cell Division is recognized for its influence and relevance in the academic community. Targeting professionals, researchers, and students alike, it aims to disseminate high-quality research findings that further our understanding of cellular processes and contribute to advances in medical and biotechnological applications. Engage with leading-edge research and broaden your knowledge base in cell biology through this dynamic publication that continues to evolve through 2024 and beyond.

Cells

Exploring Innovative Pathways in Molecular Biology
Publisher: MDPIISSN: Frequency: 24 issues/year

Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Pioneering Research in Biochemistry and Cell Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

EXPERIMENTAL CELL RESEARCH

Pioneering Insights into Cellular Dynamics
Publisher: ELSEVIER INCISSN: 0014-4827Frequency: 20 issues/year

EXPERIMENTAL CELL RESEARCH is a highly respected journal published by Elsevier Inc, specializing in the dynamic and ever-evolving field of Cell Biology. With an impact factor positioned in the Q2 quartile for 2023, it ranks at the 124th position out of 285 in the Scopus Ranks, indicating a solid reputation among peers in the domains of biochemistry, genetics, and molecular biology. Since its inception in 1950, the journal has contributed significantly to the dissemination of groundbreaking research, providing a platform for studies that explore the nuances of cellular mechanisms, processes, and experimental methodologies. Although the journal currently does not offer open access, its commitment to high-quality, peer-reviewed research continues to attract submissions from leading scientists and scholars across the globe. Researchers, professionals, and students alike will find this journal an invaluable resource for keeping abreast of current developments and innovative breakthroughs in cellular science.

FEBS Journal

Elevating Scientific Discourse in Biosciences
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

Stem Cells International

Unlocking the Potential of Regenerative Medicine
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.